Patent · US Active

Treating cartilage defect with UCB-MSC expressing TSP-2

US9408892B2 · kind B2 · utility

0Cited by
1References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 19, 2013
Grant dateAug 9, 2016
Priority date—
Expiry dateSep 27, 2033

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/5005
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Thrombospondin 1 (TSP-1), TSP-2, interleukin 17B receptor (IL-17BR) and heparin-binding epidermal growth factor-like growth factor (HB-EGF) associated with stem cell activity and use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.